DK0923568T5 - Hidtil ukendte benzofuran-4-carboxamider - Google Patents

Hidtil ukendte benzofuran-4-carboxamider

Info

Publication number
DK0923568T5
DK0923568T5 DK97942858T DK97942858T DK0923568T5 DK 0923568 T5 DK0923568 T5 DK 0923568T5 DK 97942858 T DK97942858 T DK 97942858T DK 97942858 T DK97942858 T DK 97942858T DK 0923568 T5 DK0923568 T5 DK 0923568T5
Authority
DK
Denmark
Prior art keywords
carboxamides
benzofuran
newly known
newly
substituted
Prior art date
Application number
DK97942858T
Other languages
Danish (da)
English (en)
Other versions
DK0923568T3 (da
Inventor
Hermann Amschler
Ulrich Thibaut
Dietrich Haefner
Dieter Flockerzi
Armin Hatzelmann
Christian Schudt
Rolf Beume
Hans-Peter Kley
Wolf-Ruediger Ulrich
Beate Schmidt
Original Assignee
Altana Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Altana Pharma Ag filed Critical Altana Pharma Ag
Application granted granted Critical
Publication of DK0923568T3 publication Critical patent/DK0923568T3/da
Publication of DK0923568T5 publication Critical patent/DK0923568T5/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Table Devices Or Equipment (AREA)
  • Furan Compounds (AREA)
DK97942858T 1996-08-19 1997-08-13 Hidtil ukendte benzofuran-4-carboxamider DK0923568T5 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19633052 1996-08-19
PCT/EP1997/004398 WO1998007715A1 (de) 1996-08-19 1997-08-13 Novel benzofuran-4-carboxamides

Publications (2)

Publication Number Publication Date
DK0923568T3 DK0923568T3 (da) 2003-04-07
DK0923568T5 true DK0923568T5 (da) 2003-11-03

Family

ID=7802799

Family Applications (1)

Application Number Title Priority Date Filing Date
DK97942858T DK0923568T5 (da) 1996-08-19 1997-08-13 Hidtil ukendte benzofuran-4-carboxamider

Country Status (11)

Country Link
US (1) US6211203B1 (de)
EP (1) EP0923568B9 (de)
JP (1) JP4309475B2 (de)
AT (1) ATE229516T1 (de)
AU (1) AU4454597A (de)
CY (1) CY2458B1 (de)
DE (1) DE69717827T2 (de)
DK (1) DK0923568T5 (de)
ES (1) ES2188983T4 (de)
PT (1) PT923568E (de)
WO (1) WO1998007715A1 (de)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUP0100042A3 (en) * 1996-05-20 2003-01-28 Darwin Discovery Ltd Cambridge Benzofuran carboxamides medicaments containing the same and their therapeutic use
WO1999040085A1 (en) * 1998-02-09 1999-08-12 Darwin Discovery Limited Benzofuran-4-carboxamides and their therapeutic use
TW555759B (en) * 1998-06-08 2003-10-01 Darwin Discovery Ltd Heterocyclic compounds and their therapeutic use
US6303789B1 (en) * 1998-06-10 2001-10-16 Byk Gulden Lomberg Chemische Fabrik Gmbh Benzamides with tetrahydrofuranyloxy substitutents as phosphodiesterase 4 inhibitors
EP1129068A1 (de) * 1998-11-12 2001-09-05 Ariad Pharmaceuticals, Inc. Bizyclische inhibitoren von signal-transduktion, sie enthaltende zusammensetzungen und ihre verwendungen
DE19924340A1 (de) 1999-05-27 2000-11-30 Basf Ag Verfahren zur selektiven Hydrierung von ethylenisch ungesättigten Doppelbindungen in Polymeren
NZ517166A (en) 1999-08-21 2004-01-30 Altana Pharma Ag Synergistic combination of PDE inhibitors and beta 2 adrenoceptor agonists
GB0003257D0 (en) 2000-02-11 2000-04-05 Darwin Discovery Ltd Heterocyclic compounds and their therapeutic use
EP2258357A3 (de) 2005-08-26 2011-04-06 Braincells, Inc. Neurogenese mit Acetylcholinesterasehemmer
CA2620333A1 (en) 2005-08-26 2007-03-01 Braincells, Inc. Neurogenesis by muscarinic receptor modulation
US7985756B2 (en) 2005-10-21 2011-07-26 Braincells Inc. Modulation of neurogenesis by PDE inhibition
US20070112017A1 (en) 2005-10-31 2007-05-17 Braincells, Inc. Gaba receptor mediated modulation of neurogenesis
US20100216734A1 (en) 2006-03-08 2010-08-26 Braincells, Inc. Modulation of neurogenesis by nootropic agents
US7842713B2 (en) * 2006-04-20 2010-11-30 Pfizer Inc Fused phenyl amido heterocyclic compounds
JP2009536669A (ja) 2006-05-09 2009-10-15 ブレインセルス，インコーポレイティド アンジオテンシン調節による神経新生
MX2008014320A (es) 2006-05-09 2009-03-25 Braincells Inc Neurogenesis mediada por el receptor de 5-hidroxitriptamina.
AU2007292848A1 (en) 2006-09-08 2008-03-13 Braincells, Inc. Combinations containing a 4-acylaminopyridine derivative
US20100184806A1 (en) 2006-09-19 2010-07-22 Braincells, Inc. Modulation of neurogenesis by ppar agents
JP4907746B2 (ja) 2008-09-11 2012-04-04 ファイザー・インク ヘテロアリールアミド誘導体およびグルコキナーゼ活性化因子としてのその使用
AR074760A1 (es) * 2008-12-18 2011-02-09 Metabolex Inc Agonistas del receptor gpr120 y usos de los mismos en medicamentos para el tratamiento de diabetes y el sindrome metabolico.
US20100216805A1 (en) 2009-02-25 2010-08-26 Braincells, Inc. Modulation of neurogenesis using d-cycloserine combinations
NZ595024A (en) 2009-03-11 2013-01-25 Pfizer Benzofuranyl derivatives used as glucokinase inhibitors
RU2446143C2 (ru) * 2010-05-19 2012-03-27 Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Ярославский государственный технический университет" (ЯГТУ) Способ получения эфиров замещенных 5,6-дицианобензофуран-2-карбоновых кислот
DK2582674T3 (en) * 2010-06-16 2014-12-15 Cymabay Therapeutics Inc GPR120 receptor agonists and uses thereof.
US8299117B2 (en) 2010-06-16 2012-10-30 Metabolex Inc. GPR120 receptor agonists and uses thereof
EP2804603A1 (de) 2012-01-10 2014-11-26 President and Fellows of Harvard College Betazellen-replikation für promoterverbindungen und verwendungsverfahren dafür
US11390614B2 (en) 2017-11-10 2022-07-19 Jiangsu Hengrui Medicine Co., Ltd. Method for preparing benzofuran derivative

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3093271B2 (ja) * 1993-07-02 2000-10-03 ビイク グルデン ロンベルク ヒェーミッシェ ファブリーク ゲゼルシャフト ミット ベシュレンクテル ハフツング フルオルアルコキシ置換のベンズアミド及び環状ヌクレオチドホスホジエステラーゼ阻害剤としてのその使用
MX9700557A (es) * 1994-07-22 1997-12-31 Byk Gulden Lomberg Chem Fab Dihidrobenzofuranos.
CN1163493C (zh) * 1995-05-19 2004-08-25 协和发酵工业株式会社 含氧杂环化合物
ES2172695T3 (es) * 1995-12-05 2002-10-01 Darwin Discovery Ltd Carboxamidas y sulfonamidas de benzofurano.
HUP0100042A3 (en) * 1996-05-20 2003-01-28 Darwin Discovery Ltd Cambridge Benzofuran carboxamides medicaments containing the same and their therapeutic use

Also Published As

Publication number Publication date
AU4454597A (en) 1998-03-06
WO1998007715A1 (de) 1998-02-26
WO1998007715A9 (de) 1999-04-29
US6211203B1 (en) 2001-04-03
JP4309475B2 (ja) 2009-08-05
DE69717827D1 (de) 2003-01-23
CY2458B1 (en) 2005-06-03
ATE229516T1 (de) 2002-12-15
EP0923568B9 (de) 2003-08-13
DK0923568T3 (da) 2003-04-07
EP0923568A1 (de) 1999-06-23
JP2000516932A (ja) 2000-12-19
ES2188983T4 (es) 2004-06-01
PT923568E (pt) 2003-04-30
ES2188983T3 (es) 2003-07-01
EP0923568B1 (de) 2002-12-11
DE69717827T2 (de) 2003-09-04

Similar Documents

Publication Publication Date Title
DK0923568T5 (da) Hidtil ukendte benzofuran-4-carboxamider
EA199700061A1 (ru) Способ получения силденафила
ATE260103T1 (de) Ortho-anthranilamide derivate als antikoagulantien
ES2193252T3 (es) Quinolonas y su uso terapeutico.
DE69618231D1 (de) TETRAHYDROIMIDAZOPYRIDOINDOLDIONE ALS cGMP SPEZIFISCHE PDE HEMMER
DE69721008D1 (de) Bicyclische pyrimidine derivate und ihre verwendung als antikoagulantien
DE69516866D1 (de) Stereochemische wortmanninderivate
ATE315560T1 (de) Polyhydroxylierte heterocyclische derivate als antikoagulanten
ES2173477T3 (es) Derivados de tetrahidronaftaleno y su utilizacion terapeutica.
ATE211732T1 (de) N-benzylpiperidin- und tetrahydropyridin-derivate
DE69722656D1 (de) Bicyclische arylcarboxamide und ihre therapeutische verwendung
DE59100597D1 (de) Verwendung von N-Alkyl-lactamen als Kristallisationsinhibitoren.
ATE233252T1 (de) Substituierte dihydrobenzofurane als pde- hemmstoffe
ES2060818T3 (es) Derivados de indol, benzofurano y benzotiofeno sustituidos como inhibidores de la 5-lipooxigenasa.
WO2003018549A3 (en) Bicyclic compounds as inhibitors of chemokine binding to us28
EA200200381A1 (ru) Тетрагидротиопиранфталазиноновые производные в качестве ингибиторов pde4
FI955118A (fi) Herbisidiset substituoidut 1-fenyyli- tai 1-pyridinyyli-bentsotriatsolit
ES2104174T3 (es) Derivados de bencilamino, bencilamido y bencilimido ciclicos utilizados como agentes antipsicoticos.
NZ333854A (en) Intermediates for the preparation of 2-imidazoline-5-ones
EA200100864A1 (ru) Способ получения 1,4,7,10-тетраазациклододекана
PT1104419E (pt) Derivados de azabicicloheptano substituidos no azoto sua preparacao e utilizacao
DE59711147D1 (de) Neue Imidazo- und Oxazolopyridine als Phosphodiesterase Inhibitoren.
ES2173634T3 (es) Compuestos heterociclicos que presentan actividad inhibidora de mmp y tnf.
DE69025817D1 (de) 3-Keto-HMG-CoA Reduktase-Inhibitoren
EA199800597A1 (ru) Производные морфина с анальгетической активностью